Oramed Pharmaceuticals Inc. (ORMP.TA)
ILA 879.9
(4.22%)
ILA 879.9
(4.22%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 9.51 Million | 8.65 Million | 9.08 Million | 9.54 Million | 8.81 Million | 8.8 Million |
| Cost of Revenue | 7623.88 | 243.58 Thousand | -6368.50 | 317.76 Thousand | -287.95 Thousand | 670.7 Thousand |
| Gross Profit | 9.5 Million | 8.41 Million | 9.08 Million | 9.22 Million | 9.1 Million | 8.13 Million |
| Operating Expenses | 152.17 Million | 82.68 Million | 48.46 Million | 60.88 Million | 57.79 Million | 46.76 Million |
| Selling, General and Administrative Expenses | 55.11 Million | 19.02 Million | 14.18 Million | 13.14 Million | 14.67 Million | 9.89 Million |
| Research and Development Expenses | 97.05 Million | 63.66 Million | 34.28 Million | 47.74 Million | 43.11 Million | 36.87 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 152.37 Million | 82.93 Million | 48.48 Million | 61.2 Million | 57.5 Million | 47.44 Million |
| Operating Income | -142.86 Million | -74.27 Million | -39.4 Million | -51.65 Million | -48.68 Million | -38.63 Million |
| Interest Expense | 49.26 Thousand | 19.22 Thousand | - | - | 21.59 Thousand | 21.51 Thousand |
| Income Tax Expense | 351.9 Thousand | -3.51 Million | -2.31 Million | 1.05 Million | -3.25 Million | 1.43 Million |
| Earnings before Tax | -132.54 Million | -73.65 Million | -38.58 Million | -49.62 Million | -45.8 Million | -36.15 Million |
| Net Income | -128.65 Million | -71.24 Million | -38.58 Million | -50.68 Million | -45.8 Million | -37.58 Million |
| Earnings Per Share Basic | -3.30 | -2.50 | -1.88 | -2.90 | -3.08 | -2.82 |
| Earnings Per Share Diluted | -3.30 | -2.50 | -1.88 | -2.90 | -3.08 | -2.82 |
| Weighted Average Shares Outstanding | 38.99 Million | 28.46 Million | 20.53 Million | 17.45 Million | 14.88 Million | 13.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.99 Million | 28.46 Million | 20.53 Million | 17.45 Million | 14.88 Million | 13.3 Million |
| Gross Margin | 1.00 | 0.97 | 1.00 | 0.97 | 1.03 | 0.92 |
| EBIT Margin | -15.00 | -8.55 | -4.34 | -5.41 | -5.52 | -4.38 |
| Profit Margin | -13.53 | -8.23 | -4.25 | -5.31 | -5.20 | -4.27 |
| EBITDA | -142.66 Million | -74.02 Million | -39.38 Million | -51.63 Million | -48.66 Million | -38.61 Million |
| Earnings Before Tax Margin | -15.02 | -8.58 | -4.34 | -5.41 | -5.52 | -4.39 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 2.5 Million | 2.4 Million | 2.39 Million | 9.51 Million | 2.43 Million |
| Cost of Revenue | 206.31 Thousand | 193.15 Thousand | 133.37 Thousand | 1920.83 | 7623.88 | -1610.17 |
| Gross Profit | -206.31 Thousand | 2.31 Million | 2.26 Million | 2.39 Million | 9.5 Million | 2.43 Million |
| Operating Expenses | 10.84 Million | 16.39 Million | 21.04 Million | 36.61 Million | 152.17 Million | 31.55 Million |
| Selling, General and Administrative Expenses | 7.39 Million | 9.82 Million | 5.21 Million | 11.06 Million | - | 12.55 Million |
| Research and Development Expenses | 3.44 Million | 6.57 Million | 15.82 Million | 25.54 Million | - | 19 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 11.05 Million | 16.58 Million | 21.17 Million | 36.67 Million | 152.37 Million | 31.61 Million |
| Operating Income | -11.05 Million | -14.08 Million | -18.77 Million | -34.27 Million | -142.86 Million | -29.18 Million |
| Interest Expense | 3.15 Million | - | - | - | 49.26 Thousand | - |
| Income Tax Expense | -1.89 Million | -462.28 Thousand | -790.88 Thousand | -682 Thousand | 351.9 Thousand | 356.35 Thousand |
| Earnings before Tax | -12.54 Million | -4.87 Million | -13.01 Million | -30.74 Million | -132.54 Million | -25.48 Million |
| Net Income | -12.3 Million | -4.43 Million | -12.23 Million | -30.06 Million | -128.65 Million | -25.15 Million |
| Earnings Per Share Basic | -0.30 | -0.11 | -0.31 | -0.76 | - | -0.64 |
| Earnings Per Share Diluted | -0.30 | -0.11 | -0.31 | -0.76 | - | -0.64 |
| Weighted Average Shares Outstanding | 40.44 Million | 40.22 Million | 40.04 Million | 39.46 Million | 38.99 Million | 39.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.44 Million | 40.22 Million | 40.04 Million | 39.46 Million | 38.99 Million | 39.1 Million |
| Gross Margin | - | 0.92 | 0.94 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -5.55 | -7.76 | -14.28 | - | -11.99 |
| Profit Margin | - | -1.77 | -5.10 | -12.54 | -13.53 | -10.35 |
| EBITDA | -10.84 Million | -13.88 Million | -18.64 Million | -34.21 Million | - | -29.12 Million |
| Earnings Before Tax Margin | - | -5.62 | -7.82 | -14.30 | -15.02 | -12.01 |
603316
3476
ZOO
5455
301587
AEPT